Research and organization

 

Marketed injected peptide and protein therapeutics have a great impact on the  reatment of important systemic diseases, however, so far they cannot be administered in the fashion that has the highest patient compliance: the oral route.
 
The overall objective of TRANS-INT is to develop new oral nanocarriers and new potential oral nanomedicines for treatment of high economic impact diseases, as well as to contribute to generation of new knowledge regarding interaction of nanomaterials with the GI barriers.
 
To address this objective, the TRANS-INT research activity has been organised in different activity work packages (WP) as shown in the following figure:



research WP